<SEC-DOCUMENT>0001370368-24-000007-index.html : 20240131
<SEC-HEADER>0001370368-24-000007.hdr.sgml : 20240131
<ACCEPTANCE-DATETIME>20240131074349
ACCESSION NUMBER:		0001370368-24-000007
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240131
DATE AS OF CHANGE:		20240131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVARTIS AG
		CENTRAL INDEX KEY:			0001114448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15024
		FILM NUMBER:		24580648

	BUSINESS ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		CITY:			BASEL
		STATE:			V8
		ZIP:			CH 4056
		BUSINESS PHONE:		01141613241111

	MAIL ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		CITY:			BASEL
		STATE:			V8
		ZIP:			CH 4056
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a240131-6k.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: a240131-6k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>a240131-99_1.htm
<DESCRIPTION>99.1 FINANCIAL REPORT Q4 2023
<TEXT>
Document 2 - file: a240131-99_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>a240131-99_2.htm
<DESCRIPTION>99.2 INTERIM FINANCIAL REPORT
<TEXT>
Document 3 - file: a240131-99_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>IMAGE
<TEXT>
Document 4 - file: logo.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>coverifr.jpg
<DESCRIPTION>IMAGE
<TEXT>
Document 5 - file: coverifr.jpg

</DOCUMENT>
</SEC-DOCUMENT>